Skip to main content
Top
Published in: Virology Journal 1/2011

Open Access 01-12-2011 | Research

Effective inhibition of foot-and-mouth disease virus (FMDV) replication in vitro by vector-delivered microRNAs targeting the 3D gene

Authors: Junzheng Du, Shandian Gao, Jihuai Luo, Guofeng Zhang, Guozheng Cong, Junjun Shao, Tong Lin, Xuepeng Cai, Huiyun Chang

Published in: Virology Journal | Issue 1/2011

Login to get access

Abstract

Background

Foot-and-mouth disease virus (FMDV) causes an economically important and highly contagious disease of cloven-hoofed animals. RNAi triggered by small RNA molecules, including siRNAs and miRNAs, offers a new approach for controlling viral infections. There is no report available for FMDV inhibition by vector-delivered miRNA, although miRNA is believed to have more potential than siRNA. In this study, the inhibitory effects of vector-delivered miRNAs targeting the 3D gene on FMDV replication were examined.

Results

Four pairs of oligonucleotides encoding 3D-specific miRNA of FMDV were designed and selected for construction of miRNA expression plasmids. In the reporter assays, two of four miRNA expression plasmids were able to significantly silence the expression of 3D-GFP fusion proteins from the reporter plasmid, p3D-GFP, which was cotransfected with each miRNA expression plasmid. After detecting the silencing effects of the reporter genes, the inhibitory effects of FMDV replication were determined in the miRNA expression plasmid-transfected and FMDV-infected cells. Virus titration and real-time RT-PCR assays showed that the p3D715-miR and p3D983-miR plasmids were able to potently inhibit the replication of FMDV when BHK-21 cells were infected with FMDV.

Conclusion

Our results indicated that vector-delivered miRNAs targeting the 3D gene efficiently inhibits FMDV replication in vitro. This finding provides evidence that miRNAs could be used as a potential tool against FMDV infection.
Appendix
Available only for authorised users
Literature
1.
go back to reference Alexandersen S, Mowat GN: Foot-and-mouth disease: host range and pathogenesis. Curr Top Microbiol Immunol 2005, 288: 9-42. 10.1007/3-540-27109-0_2PubMed Alexandersen S, Mowat GN: Foot-and-mouth disease: host range and pathogenesis. Curr Top Microbiol Immunol 2005, 288: 9-42. 10.1007/3-540-27109-0_2PubMed
2.
go back to reference Thomson GR, Vosloo W, Bastos ADS: Foot and mouth disease in wildlife. Virus Res 2003, 91: 145-161. 10.1016/S0168-1702(02)00263-0CrossRefPubMed Thomson GR, Vosloo W, Bastos ADS: Foot and mouth disease in wildlife. Virus Res 2003, 91: 145-161. 10.1016/S0168-1702(02)00263-0CrossRefPubMed
4.
go back to reference Belsham GJ: Translation and replication of FMDV RNA. Curr Top Microbiol Immunol 2005, 288: 43-70. 10.1007/3-540-27109-0_3PubMed Belsham GJ: Translation and replication of FMDV RNA. Curr Top Microbiol Immunol 2005, 288: 43-70. 10.1007/3-540-27109-0_3PubMed
5.
go back to reference Du J, Chang H, Cong G, Shao J, Lin T, Shang Y, Liu Z, Liu X, Cai X, Xie Q: Complete nucleotide sequence of a Chinese serotype Asia1 vaccine strain of foot-and-mouth disease virus. Virus Genes 2007,35(3):635-642. 10.1007/s11262-007-0126-8CrossRefPubMed Du J, Chang H, Cong G, Shao J, Lin T, Shang Y, Liu Z, Liu X, Cai X, Xie Q: Complete nucleotide sequence of a Chinese serotype Asia1 vaccine strain of foot-and-mouth disease virus. Virus Genes 2007,35(3):635-642. 10.1007/s11262-007-0126-8CrossRefPubMed
6.
go back to reference Ferrer-Orta C, Agudo R, Domingo E, Verdaguer N: Structural insights into replication initiation and elongation processes by the FMDV RNA-dependent RNA polymerase. Curr Opin Struct Biol 2009,19(6):752-758. 10.1016/j.sbi.2009.10.016CrossRefPubMed Ferrer-Orta C, Agudo R, Domingo E, Verdaguer N: Structural insights into replication initiation and elongation processes by the FMDV RNA-dependent RNA polymerase. Curr Opin Struct Biol 2009,19(6):752-758. 10.1016/j.sbi.2009.10.016CrossRefPubMed
7.
go back to reference Arias A, Arnold JJ, Sierra M, Smidansky ED, Domingo E, Cameron CE: Determinants of RNA-dependent RNA polymerase (in)fidelity revealed by kinetic analysis of the polymerase encoded by a foot-and-mouth disease virus mutant with reduced sensitivity to ribavirin. J Virol 2008, 82: 12346-12355. 10.1128/JVI.01297-08PubMedCentralCrossRefPubMed Arias A, Arnold JJ, Sierra M, Smidansky ED, Domingo E, Cameron CE: Determinants of RNA-dependent RNA polymerase (in)fidelity revealed by kinetic analysis of the polymerase encoded by a foot-and-mouth disease virus mutant with reduced sensitivity to ribavirin. J Virol 2008, 82: 12346-12355. 10.1128/JVI.01297-08PubMedCentralCrossRefPubMed
8.
go back to reference Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC: Potent and specific genetic interference by double-stranded RNA in C . elegans. Nature 1998, 391: 806-811. 10.1038/35888CrossRefPubMed Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC: Potent and specific genetic interference by double-stranded RNA in C . elegans. Nature 1998, 391: 806-811. 10.1038/35888CrossRefPubMed
9.
go back to reference Elbashir S M, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411: 494-498. 10.1038/35078107CrossRefPubMed Elbashir S M, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411: 494-498. 10.1038/35078107CrossRefPubMed
10.
go back to reference Cullen BR: Derivation and function of small interfering RNAs and microRNAs. Virus Res 2004, 102: 3-9. 10.1016/j.virusres.2004.01.009CrossRefPubMed Cullen BR: Derivation and function of small interfering RNAs and microRNAs. Virus Res 2004, 102: 3-9. 10.1016/j.virusres.2004.01.009CrossRefPubMed
11.
go back to reference Chen W, Liu M, Jiao Y, Yan W, Wei X, Chen J, Fei L, Liu Y, Zuo X, Yang F, Lu Y, Zheng Z: Adenovirus-mediated RNA interference against foot-and mouth disease virus infection both in vitro and in vivo. J Virol 2006,80(7):3559-3566. 10.1128/JVI.80.7.3559-3566.2006PubMedCentralCrossRefPubMed Chen W, Liu M, Jiao Y, Yan W, Wei X, Chen J, Fei L, Liu Y, Zuo X, Yang F, Lu Y, Zheng Z: Adenovirus-mediated RNA interference against foot-and mouth disease virus infection both in vitro and in vivo. J Virol 2006,80(7):3559-3566. 10.1128/JVI.80.7.3559-3566.2006PubMedCentralCrossRefPubMed
12.
go back to reference Chen W, Yan W, Du Q, Fei L, Liu M, Ni Z, Sheng Z, Zheng Z: RNA interference targeting VP1 inhibits foot-and-mouth disease virus replication in BHK-21 cells and suckling mice. J Virol 2004,78(13):6900-6907. 10.1128/JVI.78.13.6900-6907.2004PubMedCentralCrossRefPubMed Chen W, Yan W, Du Q, Fei L, Liu M, Ni Z, Sheng Z, Zheng Z: RNA interference targeting VP1 inhibits foot-and-mouth disease virus replication in BHK-21 cells and suckling mice. J Virol 2004,78(13):6900-6907. 10.1128/JVI.78.13.6900-6907.2004PubMedCentralCrossRefPubMed
13.
go back to reference de los Santos T, Wu Q, Botton S, Grubman MJ: Short hairpin RNA targeted to the highly conserved 2B nonstructural protein coding region inhibits replication of multiple serotypes of foot-and-mouth disease virus. Virology 2005,335(2):222-231. 10.1016/j.virol.2005.03.001CrossRefPubMed de los Santos T, Wu Q, Botton S, Grubman MJ: Short hairpin RNA targeted to the highly conserved 2B nonstructural protein coding region inhibits replication of multiple serotypes of foot-and-mouth disease virus. Virology 2005,335(2):222-231. 10.1016/j.virol.2005.03.001CrossRefPubMed
14.
go back to reference Kahana R, Kuznetzova L, Rogel A, Shemesh M, Hai D, Yadin H, Stram Y: Inhibition of foot-and-mouth disease virus replication by small interfering RNA. J Gen Virol 2004, 85: 3213-3217. 10.1099/vir.0.80133-0CrossRefPubMed Kahana R, Kuznetzova L, Rogel A, Shemesh M, Hai D, Yadin H, Stram Y: Inhibition of foot-and-mouth disease virus replication by small interfering RNA. J Gen Virol 2004, 85: 3213-3217. 10.1099/vir.0.80133-0CrossRefPubMed
15.
go back to reference Kim SM, Lee KN, Park JY, Ko YJ, Joo YS, Kim HS, Park JH: Therapeutic application of RNA interference against foot-and-mouth disease virus in vitro and in vivo. Antiviral Res 2008, 80: 178-184. 10.1016/j.antiviral.2008.06.001CrossRefPubMed Kim SM, Lee KN, Park JY, Ko YJ, Joo YS, Kim HS, Park JH: Therapeutic application of RNA interference against foot-and-mouth disease virus in vitro and in vivo. Antiviral Res 2008, 80: 178-184. 10.1016/j.antiviral.2008.06.001CrossRefPubMed
16.
go back to reference Wang P, Ren Y, Guo Z, Chen C: Inhibition of foot-and-mouth disease virus replication in vitro and in vivo by small interfering RNA. Virol J 2008, 5: 86. 10.1186/1743-422X-5-86CrossRef Wang P, Ren Y, Guo Z, Chen C: Inhibition of foot-and-mouth disease virus replication in vitro and in vivo by small interfering RNA. Virol J 2008, 5: 86. 10.1186/1743-422X-5-86CrossRef
17.
go back to reference Chung KH, Hart CC, Al-Bassam S, Avery A, Taylor J, Patel PD, Vojtek AB, Turner DL: Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155. Nucleic Acids Res 2006, 34: e53. 10.1093/nar/gkl143PubMedCentralCrossRefPubMed Chung KH, Hart CC, Al-Bassam S, Avery A, Taylor J, Patel PD, Vojtek AB, Turner DL: Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155. Nucleic Acids Res 2006, 34: e53. 10.1093/nar/gkl143PubMedCentralCrossRefPubMed
18.
go back to reference Stegmeier F, Hu G, Rickles RJ, Hannon GJ, Elledge SJ: A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells. Proc Natl Acad Sci USA 2005, 102: 13212-13217. 10.1073/pnas.0506306102PubMedCentralCrossRefPubMed Stegmeier F, Hu G, Rickles RJ, Hannon GJ, Elledge SJ: A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells. Proc Natl Acad Sci USA 2005, 102: 13212-13217. 10.1073/pnas.0506306102PubMedCentralCrossRefPubMed
19.
go back to reference Boden D, Pusch O, Lee F, Tucker L, Ramratnam B: Human immunodeficiency virus type 1 escape from RNA interference. J Virol 2003, 77: 11531-11535. 10.1128/JVI.77.21.11531-11535.2003PubMedCentralCrossRefPubMed Boden D, Pusch O, Lee F, Tucker L, Ramratnam B: Human immunodeficiency virus type 1 escape from RNA interference. J Virol 2003, 77: 11531-11535. 10.1128/JVI.77.21.11531-11535.2003PubMedCentralCrossRefPubMed
21.
go back to reference McBride JL, Boudreau RL, Harper SQ, Staber PD, Monteys AM, Martins I, Gilmore BL, Burstein H, Peluso RW, Polisky B, Carter BJ, Davidson BL: Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc Natl Acad Sci USA 2008, 105: 5868-5873. 10.1073/pnas.0801775105PubMedCentralCrossRefPubMed McBride JL, Boudreau RL, Harper SQ, Staber PD, Monteys AM, Martins I, Gilmore BL, Burstein H, Peluso RW, Polisky B, Carter BJ, Davidson BL: Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc Natl Acad Sci USA 2008, 105: 5868-5873. 10.1073/pnas.0801775105PubMedCentralCrossRefPubMed
22.
go back to reference Zhang X, Liu Z, Zhao Q, Chang H, Xie Q: Sequencing and analysis for the full-length genome RNA of foot-and-mouth disease virus China/99. Sci China C Life Sci 2004,47(1):74-81. 10.1360/02yc0169CrossRefPubMed Zhang X, Liu Z, Zhao Q, Chang H, Xie Q: Sequencing and analysis for the full-length genome RNA of foot-and-mouth disease virus China/99. Sci China C Life Sci 2004,47(1):74-81. 10.1360/02yc0169CrossRefPubMed
23.
go back to reference Reed LJ, Muench HA: A Simple method of estimating fifty percent end points. Am J Hyg 1938, 27: 493-497. Reed LJ, Muench HA: A Simple method of estimating fifty percent end points. Am J Hyg 1938, 27: 493-497.
24.
go back to reference Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2 --ΔΔCt method. Methods 2001, 25: 402-408. 10.1006/meth.2001.1262CrossRefPubMed Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2 --ΔΔCt method. Methods 2001, 25: 402-408. 10.1006/meth.2001.1262CrossRefPubMed
25.
go back to reference Du J, Chang H, Gao S, Xue S, Cong G, Shao J, Lin T, Liu Z, Liu X, Cai X: Molecular characterization and expression analysis of porcine integrins αvβ3, αvβ6 and αvβ8 that are potentially involved in FMDV infection. Mol Cell Probes 2010, 24: 256-265. 10.1016/j.mcp.2010.04.005CrossRefPubMed Du J, Chang H, Gao S, Xue S, Cong G, Shao J, Lin T, Liu Z, Liu X, Cai X: Molecular characterization and expression analysis of porcine integrins αvβ3, αvβ6 and αvβ8 that are potentially involved in FMDV infection. Mol Cell Probes 2010, 24: 256-265. 10.1016/j.mcp.2010.04.005CrossRefPubMed
26.
go back to reference Lim TW, Yuan J, Liu Z, Qiu D, Sall A, Yang D: Nucleic-acid based antiviral agents against positive single-stranded RNA viruses. Curr Opin Mol Ther 2006,8(2):104-107.PubMed Lim TW, Yuan J, Liu Z, Qiu D, Sall A, Yang D: Nucleic-acid based antiviral agents against positive single-stranded RNA viruses. Curr Opin Mol Ther 2006,8(2):104-107.PubMed
27.
go back to reference Voinnet O: Induction and suppression of RNA silencing: insights from viral infections. Nat Rev Genet 2005,6(3):206-220. 10.1038/nrg1555CrossRefPubMed Voinnet O: Induction and suppression of RNA silencing: insights from viral infections. Nat Rev Genet 2005,6(3):206-220. 10.1038/nrg1555CrossRefPubMed
28.
go back to reference Spurgers KB, Sharkey MC, Warfield KL, Bavari S: Oligonucleotide antiviral therapeutics: Antisense and RNA interference for highly pathogenic RNA viruses. Antiviral Res 2008, 78: 26-36. 10.1016/j.antiviral.2007.12.008CrossRefPubMed Spurgers KB, Sharkey MC, Warfield KL, Bavari S: Oligonucleotide antiviral therapeutics: Antisense and RNA interference for highly pathogenic RNA viruses. Antiviral Res 2008, 78: 26-36. 10.1016/j.antiviral.2007.12.008CrossRefPubMed
29.
go back to reference Zeng Y, Yi R, Cullen BR: MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc Natl Acad Sci USA 2003, 100: 9779-9784. 10.1073/pnas.1630797100PubMedCentralCrossRefPubMed Zeng Y, Yi R, Cullen BR: MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc Natl Acad Sci USA 2003, 100: 9779-9784. 10.1073/pnas.1630797100PubMedCentralCrossRefPubMed
30.
go back to reference Bartel D P: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116: 281-297. 10.1016/S0092-8674(04)00045-5CrossRefPubMed Bartel D P: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116: 281-297. 10.1016/S0092-8674(04)00045-5CrossRefPubMed
31.
go back to reference Ying SY, Chang DC, Miller JD, Lin SL: The microRNA: overview of the RNA gene that modulates gene functions. Methods Mol Biol 2006, 342: 1-18.PubMed Ying SY, Chang DC, Miller JD, Lin SL: The microRNA: overview of the RNA gene that modulates gene functions. Methods Mol Biol 2006, 342: 1-18.PubMed
32.
go back to reference Miska EA: How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 2005, 15: 563-568. 10.1016/j.gde.2005.08.005CrossRefPubMed Miska EA: How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 2005, 15: 563-568. 10.1016/j.gde.2005.08.005CrossRefPubMed
33.
go back to reference Tan FL, Yin JQ: RNAi, a new therapeutic strategy against viral infection. Cell Res 2004, 14: 460-466. 10.1038/sj.cr.7290248CrossRefPubMed Tan FL, Yin JQ: RNAi, a new therapeutic strategy against viral infection. Cell Res 2004, 14: 460-466. 10.1038/sj.cr.7290248CrossRefPubMed
34.
go back to reference Pushparaj PN, Melendez AJ: Short interfering RNA (siRNA) as a novel therapeutic. Clin Exp Pharmacol Physiol 2006, 33: 504-510. 10.1111/j.1440-1681.2006.04399.xCrossRefPubMed Pushparaj PN, Melendez AJ: Short interfering RNA (siRNA) as a novel therapeutic. Clin Exp Pharmacol Physiol 2006, 33: 504-510. 10.1111/j.1440-1681.2006.04399.xCrossRefPubMed
35.
go back to reference Gao YF, Yu L, Wei W, Li JB, Luo QL, Shen JL: Inhibition of hepatitis B virus gene expression and replication by artificial microRNA. World J Gastroenterol 2008,14(29):4684-4689. 10.3748/wjg.14.4684PubMedCentralCrossRefPubMed Gao YF, Yu L, Wei W, Li JB, Luo QL, Shen JL: Inhibition of hepatitis B virus gene expression and replication by artificial microRNA. World J Gastroenterol 2008,14(29):4684-4689. 10.3748/wjg.14.4684PubMedCentralCrossRefPubMed
36.
go back to reference Israsenaa N, Supavonwongb P, Ratanasetyuthb N, Khawplodc P, Hemachudha T: Inhibition of rabies virus replication by multiple artificial microRNAs. Antiviral Res 2009, 84: 76-83. 10.1016/j.antiviral.2009.07.012CrossRef Israsenaa N, Supavonwongb P, Ratanasetyuthb N, Khawplodc P, Hemachudha T: Inhibition of rabies virus replication by multiple artificial microRNAs. Antiviral Res 2009, 84: 76-83. 10.1016/j.antiviral.2009.07.012CrossRef
37.
go back to reference Lecellier CH, Dunoyer P, Arar K, Lehmann-Che J, Eyquem S, Himber C, Saib A, Voinnet O: A cellular microRNA mediates antiviral defense in human cells. Science 2005, 308: 557-560. 10.1126/science.1108784CrossRefPubMed Lecellier CH, Dunoyer P, Arar K, Lehmann-Che J, Eyquem S, Himber C, Saib A, Voinnet O: A cellular microRNA mediates antiviral defense in human cells. Science 2005, 308: 557-560. 10.1126/science.1108784CrossRefPubMed
38.
go back to reference Xia XG, Zhou H, Xu Z: Multiple shRNAs expressed by an inducible pol II promoter can knock down the expression of multiple target genes. Biotechniques 2006, 41: 64-68. 10.2144/000112198CrossRefPubMed Xia XG, Zhou H, Xu Z: Multiple shRNAs expressed by an inducible pol II promoter can knock down the expression of multiple target genes. Biotechniques 2006, 41: 64-68. 10.2144/000112198CrossRefPubMed
Metadata
Title
Effective inhibition of foot-and-mouth disease virus (FMDV) replication in vitro by vector-delivered microRNAs targeting the 3D gene
Authors
Junzheng Du
Shandian Gao
Jihuai Luo
Guofeng Zhang
Guozheng Cong
Junjun Shao
Tong Lin
Xuepeng Cai
Huiyun Chang
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2011
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-8-292

Other articles of this Issue 1/2011

Virology Journal 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.